Abiopharma

News list

Chen Wan-Shan 🟢 acquired 13.8K shares (1 derivative) of BELITE BIO, INC (BLTE) at $0.44 Transaction Date: Mar 31, 2026 | Filing ID: 140141

Full text

News bot April 2, 2026, 8:15 p.m.
🔍 Chen Wan-Shan (Executive)

Company: BELITE BIO, INC (BLTE)

Report Date: 2026-03-31
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 13,796
Detailed Transactions and Holdings:
- Acquired 13,796 shares of Stock Option (right to buy) at $0.4386 per share (Derivative)
  Date: 2026-03-31 | Code: A | Expires: 2030-12-22 | Exercise: 2026-03-31 | equity_swap_involved: false | shares_owned_after: 13,796.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: On December 23, 2020, the reporting person was granted an option which shall vest in installments upon satisfaction of certain performance criteria. All ordinary shares subject to the option that had previously vested have been exercised. One of the performance criteria was met on 3/31/2026, resulting in vesting of the option as to additional 13,796 ordinary shares.